arrow
A

Andrew M. Waters

University of Cincinnati College of Medicine
H指数:18
被引数:3,013

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Defining the MYC-regulated transcriptome and kinome that support KRAS- and ERK-dependent growth of pancreatic cancer

定义支持胰腺癌KRAS-和ERK依赖性生长的MYC调控转录组与激酶组

2025-09-300
PRE
Human pancreatic cancer single cell atlas reveals association of CXCL10 positive fibroblasts and basal subtype tumor cells
2024-09-150
PRE
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers

介质激酶抑制阻碍转录可塑性并阻止KRAS突变癌症对ERK/MAPK靶向治疗的抗性

2024-05-312
OAAI
TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors

TEAD抑制克服了YAP1/TAZ驱动的对KRASG12C抑制剂的原发性和获得性抗性

2023-11-0718
OA
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer

联合CDK4/6抑制剂治疗KRAS突变型胰腺癌

2022-11-0857
OA
Functional and biological heterogeneity of KRASQ61 mutations

KRASQ61突变的功能和生物学异质性

2022-08-0915
OA
Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell Carcinoma

同时抑制ERK和法尼基转移酶抑制HRAS突变型头颈部鳞状细胞癌的生长

2022-02-2814
OA
Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth

ECT2的异常表达和亚细胞定位驱动结直肠癌的进展和生长

2022-01-0423
OA
CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment

CHK1保护致癌KRAS表达细胞免受DNA损伤,是胰腺癌治疗的靶点

2021-11-0123
OAAI
Targeting p130Cas-and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition

靶向p130Cas-and微管依赖的MYC调节使胰腺癌对ERK MAPK抑制敏感

2021-06-0118
OAAI
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers

Raf-mek-erk级联的低剂量垂直抑制导致KRAS突变型癌症的凋亡死亡

2020-06-0171
OAAI
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer (vol 25, pg 628, 2019)

ERK和自噬抑制的组合作为胰腺癌的治疗方法 (第25卷,628页,2019)

2020-06-0117
OAAI
Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer

非典型KRASG12R突变体在胰腺癌的PI3K信号传导和巨胞饮作用中受损

2020-01-09139
OAAI